Why Tempus AI Skyrocketed This Week
Tempus AI stock surged 39.5% this week following positive Phase 3 trial results for a cancer vaccine developed by Merck and Moderna using technology from Personalis, which Tempus is acquiring.
Tempus AI stock surged 39.5% this week following positive Phase 3 trial results for a cancer vaccine developed by Merck and Moderna using technology from Personalis, which Tempus is acquiring.
Bitcoin rebounded to nearly $80,000 following Treasury Secretary Scott Bessent’s announcement of increased debt buybacks, while U.S. federal debt reached $40 trillion this week.
Warner Bros. Discovery reported a 10% increase in streaming revenue to over $3 billion in the second quarter, driven by HBO Max growth ahead of its proposed Paramount merger.
Disney CEO Josh D’Amaro told CNBC that the parks division delivered a “big surprise” last quarter, expressing confidence in the company’s trajectory and stating he feels “pretty good” about developments nearly six months into his tenure.
Alibaba’s shares declined as the Chinese tech giant reported a 75% drop in net income for the June quarter, driven by substantial increases in artificial intelligence spending and capital expenditure.
Three trading firms maintain over $600 million in combined short positions in Bitcoin and Ethereum despite a recent market rally that liquidated other bearish traders.